A critical advance in cancer study is occurring with the use of mini-antibodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently lost in many kinds of cancer, leading uncontrolled cell https://bookmark-template.com/story30160657/mini-antibodies-restore-p53-a-potential-pathway-for-tumor-management